{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:01:22Z","timestamp":1793970082520,"version":"4.8.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["252300421271"],"award-info":[{"award-number":["252300421271"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["242300421197"],"award-info":[{"award-number":["242300421197"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["252102311207"],"award-info":[{"award-number":["252102311207"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82020108030"],"award-info":[{"award-number":["82020108030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20416"],"award-info":[{"award-number":["U21A20416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270290"],"award-info":[{"award-number":["82270290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejmech.2025.117837","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T11:08:31Z","timestamp":1749467311000},"page":"117837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of novel pyridazinone-based EED inhibitors for prostate cancer"],"prefix":"10.1016","volume":"296","author":[{"given":"Zhang-Xu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-xuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengyangzong","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-jun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2025.117837_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chembiol.2019.11.004","article-title":"EED-targeted PROTACs degrade EED, EZH2, and SUZ12 in the PRC2 complex","volume":"27","author":"Hsu","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117837_bib2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1021\/acs.jmedchem.7b00287","article-title":"Allosteric inactivation of polycomb repressive complex 2 (PRC2) by inhibiting its adapter protein: embryonic ectodomain development (EED)","volume":"60","author":"Yang","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117837_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11316","article-title":"Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2","volume":"7","author":"Justin","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117837_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.molcel.2014.12.020","article-title":"Jarid2 methylation via the PRC2 complex regulates H3K27me3 deposition during cell differentiation","volume":"57","author":"Sanulli","year":"2015","journal-title":"Mol. Cell"},{"issue":"6258","key":"10.1016\/j.ejmech.2025.117837_bib5","article-title":"Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2","volume":"350","author":"Jiao","year":"2015","journal-title":"Sci. Technol. Humanit."},{"key":"10.1016\/j.ejmech.2025.117837_bib6","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1038\/ncomms4127","article-title":"The central role of EED in the orchestration of polycomb group complexes","volume":"5","author":"Cao","year":"2014","journal-title":"Nat. Commun."},{"issue":"7265","key":"10.1016\/j.ejmech.2025.117837_bib7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature08398","article-title":"Role of the polycomb protein EED in the propagation of repressive histone marks","volume":"461","author":"Margueron","year":"2009","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.ejmech.2025.117837_bib8","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/pros.24602","article-title":"Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer","volume":"83","author":"Zhang","year":"2023","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117837_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41422-021-00606-6","article-title":"Mechanisms of polycomb group protein function in cancer","volume":"32","author":"Parreno","year":"2022","journal-title":"Cell Res."},{"issue":"17","key":"10.1016\/j.ejmech.2025.117837_bib10","doi-asserted-by":"crossref","first-page":"9574","DOI":"10.3390\/ijms23179574","article-title":"Critical roles of polycomb repressive complexes in transcription and cancer","volume":"23","author":"Dong","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117837_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41580-021-00341-1","article-title":"The roles of polycomb repressive complexes in mammalian development and cancer","volume":"22","author":"Piunti","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117837_bib12","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117837_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccell.2015.12.006","article-title":"Polycomb repressive complex 2 is a barrier to KRAS-driven inflammation and epithelial-mesenchymal transition in non-small-cell lung cancer","volume":"29","author":"Serresi","year":"2016","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117837_bib14","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1158\/0008-5472.CAN-11-3546","article-title":"Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer","volume":"72","author":"Ren","year":"2012","journal-title":"Cancer Res."},{"issue":"6907","key":"10.1016\/j.ejmech.2025.117837_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nature01042","article-title":"FGFR-related gene nou-darake restricts brain tissues to the head region of planarians","volume":"419","author":"Cebria","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117837_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/bies.201500162","article-title":"Mutations and deletions of PRC2 in prostate cancer","volume":"38","author":"Jain","year":"2016","journal-title":"Bioessays"},{"issue":"16","key":"10.1016\/j.ejmech.2025.117837_bib17","doi-asserted-by":"crossref","first-page":"11774","DOI":"10.1021\/acs.jmedchem.1c00226","article-title":"Polycomb repressive complex 2 modulation through the development of EZH2-EED interaction inhibitors and EED binders","volume":"64","author":"Tomassi","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117837_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114144","article-title":"Recent strategies targeting embryonic ectoderm development (EED) for cancer therapy: allosteric inhibitors, PPI inhibitors, and PROTACs","volume":"231","author":"Zhao","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2025.117837_bib19","doi-asserted-by":"crossref","first-page":"15344","DOI":"10.1021\/acs.jmedchem.0c01344","article-title":"Small molecule approaches for targeting the polycomb repressive complex 2 (PRC2) in cancer","volume":"63","author":"Martin","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117837_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.6004\/jadpro.2022.13.2.7","article-title":"Tazemetostat: EZH2 inhibitor","volume":"13","author":"Straining","year":"2022","journal-title":"J. Adv. Pract. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117837_bib21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/acs.jmedchem.2c02028","article-title":"Structure-based design of the indole-substituted triazolopyrimidines as new EED-H3K27me3 inhibitors for the treatment of lymphoma","volume":"66","author":"Dong","year":"2022","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117837_bib22","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1021\/acs.jmedchem.1c02148","article-title":"Discovery of the clinical candidate MAK683: an EED-directed, allosteric, and selective PRC2 inhibitor for the treatment of advanced malignancies","volume":"66","author":"Huang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117837_bib23","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41416-023-02359-y","article-title":"Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models","volume":"129","author":"Li","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"19","key":"10.1016\/j.ejmech.2025.117837_bib24","doi-asserted-by":"crossref","first-page":"14540","DOI":"10.1021\/acs.jmedchem.1c01059","article-title":"Discovery of EEDi-5273 as an exceptionally potent and orally efficacious EED inhibitor capable of achieving complete and persistent tumor regression","volume":"64","author":"Rej","year":"2021","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2025.117837_bib25","doi-asserted-by":"crossref","first-page":"17146","DOI":"10.1021\/acs.jmedchem.1c01161","article-title":"Diverse, potent, and efficacious inhibitors that target the EED subunit of the polycomb repressive complex 2 methyltransferase","volume":"64","author":"Bagal","year":"2021","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2025.117837_bib26","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1021\/acs.jmedchem.0c00479","article-title":"EEDi-5285: an exceptionally potent, efficacious, and orally active small-molecule inhibitor of embryonic ectoderm development","volume":"63","author":"Rej","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117837_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.chembiol.2019.11.006","article-title":"Degradation of polycomb repressive complex 2 with an EED-targeted bivalent chemical degrader","volume":"27","author":"Potjewyd","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117837_bib28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nchembio0817-922b","article-title":"The eed protein-protein interaction inhibitor a-395 inactivates the PRC2 complex","volume":"13","author":"He","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117837_bib29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nchembio.2304","article-title":"An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of eed","volume":"13","author":"Wei Qi","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117837_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejmech.2017.01.002","article-title":"New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: synthesis, pharmacological data and molecular docking","volume":"127","author":"Ragusa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2025.117837_bib31","doi-asserted-by":"crossref","first-page":"18699","DOI":"10.1021\/acs.jmedchem.4c00713","article-title":"Discovery of 1,2,4-triazole-3-thione derivatives as potent and selective DCN1 inhibitors for pathological cardiac fibrosis and remodeling","volume":"67","author":"He","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117837_bib32","first-page":"1","article-title":"Research progress on the role of lipoxygenase and its inhibitors in prostate cancer","author":"Li","year":"2024","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117837_bib33","first-page":"273","article-title":"Conditionally replicative adenovirus carrying shRNA targeting EZH2 inhibits prostate cancer growth and invasion","volume":"42","author":"Xu","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2025.117837_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111764","article-title":"Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent","volume":"184","author":"He","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117837_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115401","article-title":"DeepCancerMap: a versatile deep learning platform for target- and cell-based anticancer drug discovery","volume":"255","author":"Wu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117837_bib36","doi-asserted-by":"crossref","first-page":"10057","DOI":"10.1021\/acs.jmedchem.4c00184","article-title":"Synthetically feasible se novo molecular design of leads based on a reinforcement learning model: AI-assisted discovery of an anti-IBD lead targeting CXCR4","volume":"67","author":"Jiang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117837_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.apsb.2021.07.018","article-title":"Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis","volume":"12","author":"He","year":"2022","journal-title":"Acta Pharm. Sin. B"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:41:59Z","timestamp":1754988119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425006026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":37,"alternative-id":["S0223523425006026"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117837","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of novel pyridazinone-based EED inhibitors for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117837"}}